By continuing to use the site you agree to our Privacy & Cookies policy

New once-daily inhaler for COPD and asthma

The first once-daily inhaled corticosteroid/long acting beta2-agonist combination has been launched in the UK for treating asthma and chronic obstructive pulmonary disease.

Get unlimited access

As a subscriber you will benefit from:

  • Full online and mobile access to news and opinion stories
  • Customised email alerts straight to your inbox (over 30 alerts available)
  • 4,500 practice articles in our archive 
  • Over £500 worth of CPD learning units 
or

newsletterpromo